• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Article

Greater knowledge of B cell autoimmunity allows for specific targeting

As research continues to explore B cell autoimmunity, B cell-mediated therapies likely will pursue increasingly specific targets, says Arthur Kavanaugh, M.D.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe Now!
Related Videos
1 expert in this video
1 expert in this video
Related Content
Study Supports Dual Approach for Treatment-Resistant Vitiligo
May 23rd 2025

Study Supports Dual Approach for Treatment-Resistant Vitiligo

Derm Dispatch: Advocating for Skin and Nail Health to Spread Melanoma Awareness
May 23rd 2025

Derm Dispatch: Advocating for Skin and Nail Health to Spread Melanoma Awareness

Evolving Melanoma Outcomes and Care: Insights from Victor Gall, MD
May 23rd 2025

Evolving Melanoma Outcomes and Care: Insights from Victor Gall, MD

Derm Dispatch: Discussing Early Detection and Education With a Melanoma Survivor
May 20th 2025

Derm Dispatch: Discussing Early Detection and Education With a Melanoma Survivor

Suicide Risk Management Crucial in Dermatological Care
May 22nd 2025

Suicide Risk Management Crucial in Dermatological Care

FDA Approves Arcutis’ Roflumilast Foam for Plaque Psoriasis
May 22nd 2025

FDA Approves Arcutis’ Roflumilast Foam for Plaque Psoriasis

© 2025 MJH Life Sciences

All rights reserved.